
    
      Study design:

      Multi-center, randomized, double-blind, placebo parallel controlled

      Subjects:

      Patients with chronic subdural hematoma (CSDH)

      Sample size:

      200, including an Atorvastatin-treated group of 100 patients and a control group of 100
      subjects.
    
  